SofMedica Hellas, a member of the SofMedica Group, announces the acquisition of MediVibe, a medical technology distribution company in Greece specializing in interventional cardiology. 

The inclusion of MediVibe's cutting-edge solutions in SofMedica's portfolio underscores the company's commitment to providing medical technologies that maximize the accuracy of the medical act. These technologies (Shockwave's endovascular lithotripsy balloon catheter, ASAHI's guidewires and catheters, Abiomed's Impella heart pumps, etc.) are valuable tools for interventional cardiologists, interventional radiologists, and vascular surgeons to provide optimal care to their patients, the announcement reads. 

"As SofMedica approaches its 30th anniversary, its activities extend to six countries in Central and Southeastern Europe, enabling access to innovative technologies in the fields of oncology, cardiovascular disease, and neurodegenerative diseases," said Evangelos Kalamakis, CEO of SofMedica. "Our strong ecosystem allows us to manage our business across this geographic and cultural mosaic without compromising quality, regulatory compliance, or reliability. Our emphasis on long-term sustainability has provided us with the capital resources needed to make value-adding decisions, such as the acquisition of MediVibe. True to our mission, we have the ability to execute other strategic deals that will extend the benefits of our ecosystem to additional technologies."